It has a strong alkaline group, which can combine with the strongly acidic heparin in the body to form a stable complex, causing heparin to lose its anticoagulant activity; it can decompose the combination of heparin and antithrombin III, thereby eliminating its anticoagulant effect; it also has a mild antithrombin prokinase effect.

Used to make solutions isotonic, no direct pharmacological action is described.

This product has the effect of endopeptidase, which cuts the peptide chain of protein macromolecules into peptides with smaller molecular weight, or acts on the end of the peptide chain of protein molecules to separate amino acids. This product also has the effect of lipase, which hydrolyzes certain fats. Therefore, it can digest pus, blood accumulation, necrotic tissue, and play a role in wound purification, anti-inflammatory and swelling. In addition, it can relax the ciliary ligament and dissolve the protein structure of certain tissues in the eye.

It lowers blood sugar and affects protein and fat metabolism, including inhibiting the breakdown of glycogen and gluconeogenesis, reducing the output of glucose from the liver; promoting the liver to take in glucose and the synthesis of glycogen; promoting the uptake of glucose and amino acids by muscle and adipose tissue, promoting the synthesis and storage of protein and fat; causing the liver to produce very low-density lipoprotein and activate lipoprotein lipase, promoting the breakdown of very low-density lipoprotein; inhibiting the breakdown of fat and protein in fat and muscle, inhibiting the formation of ketone bodies and promoting the utilization of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.